Tylenol Autism and ADHD Lawsuits in 2026: Acetaminophen Pregnancy Claims, Science and Who Can File

In October 2026 the federal Tylenol litigation is active again after a federal appeals court revived hundreds of acetaminophen autism and ADHD lawsuits in July 2026 and denied reconsideration in October. The cases, consolidated as MDL No. 3043 before Judge Denise Cote in New York, allege manufacturers failed to warn pregnant women about neurodevelopmental risks. No trial or settlement has occurred.

Video explainer: complex legal and insurance topics like this one are also explained on the Problem Solved YouTube channel.

The 2026 revival: what the appeals court decided

The turning point came on July 13, 2026, when the U.S. Court of Appeals for the Second Circuit vacated the summary judgments that had ended hundreds of federal cases. Judge Cote had excluded the plaintiffs' general causation experts after a December 2023 Daubert hearing and dismissed the claims in August 2024; the appeals court ruled three of those experts used accepted methodologies and should have been allowed to testify.

In October 2026 the court denied a rehearing bid from Kenvue, the company spun off from Johnson and Johnson that markets Tylenol, sending the cases back to Judge Cote. The panel stressed it was not deciding whether acetaminophen causes autism or ADHD, only that the plaintiffs' experts could present their evidence.

Key facts

  • MDL No. 3043 (case 1:22-md-03043-DLC) in the U.S. District Court for the Southern District of New York, before Judge Denise Cote, coordinates the federal cases; the MDL was created in October 2022.
  • December 2023: Judge Cote excluded the plaintiffs' general causation experts after a Daubert hearing; August 2024: she granted summary judgment, effectively ending the federal litigation at that time.
  • July 13, 2026: the Second Circuit vacated those judgments and reinstated more than 500 lawsuits; October 2026: the court rejected Kenvue's request for reconsideration.
  • September 22, 2025: the FDA announced it was beginning a labeling-change process for acetaminophen products based on a reported association with autism and ADHD, while stating that a causal relationship had not been established.
  • 2024 JAMA study: Swedish researchers studying nearly 2.5 million children born from 1995 to 2019 found that, once siblings were compared to control for family factors, the associations essentially disappeared, with hazard ratios of 0.98 for autism and 0.98 for ADHD.

What the lawsuits allege

Plaintiffs claim that manufacturers, generic acetaminophen makers and major retailers including Walmart, CVS, Walgreens, Costco and Rite Aid failed to warn pregnant women that prenatal acetaminophen exposure could increase the risk of autism spectrum disorder or ADHD in their children. The theory is a failure-to-warn claim: had labels disclosed the asserted research, mothers and doctors could have decided differently.

Defendants dispute the allegations, arguing the labels were adequate under federal requirements and the science does not establish causation.

The science behind the claims

Large observational studies have reported associations between prenatal acetaminophen use and later autism or ADHD diagnoses. On September 22, 2025, HHS released a report on the reported associations and the FDA began a label-change process and notified physicians, while noting that causation was not established and contrary studies exist.

On the other side, a large 2024 JAMA sibling-comparison study found the associations disappeared once siblings sharing genetics and environment were compared, and the World Health Organization said in September 2025 that no conclusive evidence of a link existed. The litigation must still prove causation through admissible expert testimony.

Terms to know: MDL and Daubert

An MDL (multidistrict litigation) moves similar federal lawsuits before one judge for coordinated pretrial proceedings, including discovery and expert challenges; each case stays an individual lawsuit, not a class action. Daubert is the standard judges use to decide whether expert testimony is reliable enough to reach a jury. The December 2023 Daubert ruling excluded the plaintiffs' key experts; the July 2026 reversal reinstated three of them.

Who can file a Tylenol autism or ADHD lawsuit

Law firms generally look for families where the mother used acetaminophen during pregnancy and the child was later diagnosed with autism spectrum disorder or ADHD, including generic and store-brand products. Most cases are filed for minor children, and deadlines vary by state.

If your family may qualify, collect pharmacy and medical records showing the pregnancy, the diagnoses and the acetaminophen products used. Similar mass torts are explained in our guides to vaping lung injury lawsuits, asbestos claims and AFFF firefighting foam lawsuits.

What happens next

Back before Judge Cote, the likely sequence is more discovery, then selection of representative bellwether cases for trial; those results would shape any settlement talks. There is no settlement fund, no claim form and no guaranteed payment, and most settlements are confidential, so treat advertised payout figures as marketing.

Who Benefits From This — and Who Does Not

Who benefits most from this guide:

Parents of a child diagnosed with autism spectrum disorder or ADHD after prenatal acetaminophen exposure, including generic and store-brand products. How: collect pharmacy and medical records showing the pregnancy, the products used, and the diagnoses — those are the records law firms ask for first.

Families following the revived federal litigation, MDL No. 3043. How: more than 500 cases are back before Judge Denise Cote after the July 13, 2026 Second Circuit ruling; watch for bellwether selections, since there is no settlement fund and no claim form yet. See also our guide to <a href="https://islamicwebs.com/en/articles/tepezza-hearing-loss-lawsuit-2026-tinnitus-claims">Tepezza hearing loss lawsuits</a>, another drug-injury litigation moving through an MDL.

Anyone unsure which state deadline applies to a child's claim. How: deadlines vary by state and children are often treated differently under tolling rules — ask a mass-tort attorney early rather than waiting.

Who does not benefit:

Anyone expecting a guaranteed payment or an existing claim form. How: there is no settlement, no trial verdict, and no claim form — treat advertised payout figures as marketing.

Anyone whose child has no prenatal acetaminophen exposure or no autism or ADHD diagnosis. How: the claims turn on both elements together.

Anyone treating the appeals ruling as proof that acetaminophen causes autism or ADHD. How: the court ruled only that three plaintiffs' experts may testify — causation has not been decided by any court.

FAQ

Is the Tylenol autism lawsuit still active in 2026?

Yes. In July 2026 the U.S. Court of Appeals for the Second Circuit vacated the dismissals and sent more than 500 federal cases back to Judge Denise Cote in New York, and in October 2026 the court denied Kenvue's bid for reconsideration. The litigation is moving forward again, but no trials have been held and no settlement has been reached.

Do I need to have used brand-name Tylenol to file a claim?

No. The lawsuits cover all acetaminophen products, including generic, store-brand and combination products. What matters is prenatal acetaminophen exposure and a diagnosis of autism spectrum disorder or ADHD in the child.

What is the deadline to file a Tylenol autism lawsuit?

Deadlines vary by state and claim type, and children are often treated differently under tolling rules. An attorney can explain which state's deadline applies, but do not wait: missed deadlines can end a claim permanently.

Has any court decided that Tylenol causes autism or ADHD?

No. No court has determined that acetaminophen caused any plaintiff's condition, and there has been no trial or settlement. The appeals court ruled only that plaintiffs' experts may present their evidence, not that acetaminophen causes autism or ADHD.

Who benefits most from the Tylenol autism lawsuits — and who does not?

Families benefit most when the mother used acetaminophen during pregnancy and the child was later diagnosed with autism spectrum disorder or ADHD, including generic and store-brand products. They do not benefit if they expect a guaranteed payment: there is no settlement fund and no claim form yet. And the July 2026 appeals ruling is not a causation finding — it only lets plaintiffs' experts present their evidence.

How do I start a Tylenol autism claim?

Collect pharmacy and medical records showing the pregnancy, the acetaminophen products used, and the child's diagnosis; check which state's deadline applies, keeping in mind that tolling rules for minors differ; and consult a mass-tort attorney early. There is no claim form to file while MDL No. 3043 proceeds before Judge Cote.

This article is for general information only and is not legal advice. Laws and deadlines vary by state; consult a licensed attorney about your situation.

Watch on YouTube

Problem Solved on YouTube